AID Cann · raw details

Medical Cannabis Products · Tel Aviv-Yafo · Founded 1993

acquired Public ← back to profile

Highlights

1 patent

About

Medical Cannabis Products

AID Cann is a vertically integrated medical cannabis company focused on the cultivation, manufacture, distribution, and creation of products and dosage forms for medical cannabis products. The company holds initial licenses for the entire supply chain, including growing, breeding, and nursery; production of medical cannabis products; research and development; and distribution.

The company produces its own cannabis by way of a partnership with Amit Farms, which is located in the south of Israel and designated for cannabis growth. The farm uses innovative agricultural technologies to grow high-quality cannabis and to develop Univos strains designed to meet specific therapeutic needs.

AID Cann manufacturing facility produces a wide variety of medical cannabis products that meet the most stringent international standards. The plant is IMC-GMP certified and began production in Q3 2019. The company uses ethanol and CO2-based extraction technologies to manufacture a wide range of medical cannabis products. Additional technologies will be added to enable different delivery systems and dosages to meet the needs of the products in its R&D pipeline.

Identity

NameAID Cann
Slugaid-cann
Former namesD-Pharm, Univo
Type / kindstartup
Crunchbase IDd-pharm-ltd
Source _idagxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgJ6b-PgLDA

Status

Statusacquired
Status reasonAcquired by Limited 1498 on Dec, 2024
Last update2026-05-17

Location

HQ country codeIL
HQ region/districtCenter District
HQ cityTel Aviv-Yafo
HQ addressHaArba'a Street 30, Tel Aviv-Yafo, Israel

Web & social

Websitehttps://aidcann.co.il/
LinkedInhttps://www.linkedin.com/company/12614994
Instagramhttps://www.instagram.com/univo_pharma

Classifications

Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical CannabisAgriculture & Food TechnologiesAg TechFarm Equipment & Treatment
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business models
B2B2C
Tags
pharmaceuticalsdegenerative-diseasesepilepsyneurologyagtechmedical-cannabisbreeding

Funding

Total raised$37.6M
Current stagePublic
Market cap$790K

Raw source document

Show full JSON (0 KB)
{
  "0": "s",
  "1": "l",
  "2": "i",
  "3": "m",
  "4": "p",
  "5": "a",
  "6": "g",
  "7": "e",
  "8": "s",
  "9": "_",
  "10": "i",
  "11": "m",
  "12": "p",
  "13": "o",
  "14": "r",
  "15": "t"
}